However, dysregulation of TUG1 expression in gliomas observed in these studies were not in agreement, which could be partly explained by low number of cases in the study by Cai et al. (n = 5 of each glioma grade) [36]. This evidence concerns the gene TUG1 and central nervous system cancer.